BCL2L1 and cancer: BLC2 (which was downregulated) and BCL2L1 are anti-apoptotic; IL8 and CXCL2 are chemokines that are pro-inflammatory and enhance the proliferation and survival of cancer cells (Waugh and Wilson 2008).